GTD Chronology

Working log of public facts, repo-local findings, and known gaps around GTD Healthcare, GoToDoc, Our People's Trust, New Bank, and the wider commissioner/provider environment.

How to use this note

Treat this as a timeline and context log, not as a polished narrative.
Keep public fact, working inference, and missing record clearly separate.
Include items that are only tangentially related if they help explain why GTD gets work, how GTD is structured, or which pressures shape its access model.

Pre-2020 context

1996

Mastercall's public/CQC background says it grew out of the Stockport Doctors' Co-operative.
Why it matters: Mastercall is one of the key peer organisations around GTD in the Greater Manchester urgent/community provider layer.

2005

Inquiry synthesis says David Beckett has led GTD since 2005.
Why it matters: GTD's current direction is not a sudden 2024-25 accident; there is long leadership continuity behind it.

2017

New Bank appears in the public trail as an existing APMS practice from 1 October 2017.
There was a 2017 open procurement for New Bank.
Why it matters: The 2024/25 award to GTD looks like a re-procurement / successor-contract cycle, not a one-off emergency handoff.

2018

GTD had the Stockport Special Allocation Scheme (SAS) contract from 2018.
GTD's public improvement story also includes taking over Brookdale Surgery in 2018 and later improving its CQC position.
Why it matters: GTD's commissioner-facing reputation is partly built on being willing to hold awkward contracts and turn around difficult sites.

2016 to 2020: pre-pandemic Google deterioration

Repo-local trend work suggests GTD's mean Google review score was already sliding materially before the pandemic.
The working read is:
the decline is visible by roughly 2016-2018
the score is already dropping hard before COVID-era disruption
the pandemic appears to sit inside the decline rather than cleanly causing it
Why it matters: This supports the idea of a longer-running patient-experience deterioration in ordinary day-to-day access and admin friction, rather than a simple "pandemic shock broke an otherwise healthy system" story.

2020 to 2022

2020

GTD says it moved to an employee-ownership model in 2020.
Our People's Trust is publicly described as the single shareholder of GTD Healthcare Ltd.
Simpson Medical Practice appears in the inquiry trail as registered to GoToDoc from 11 March 2020.
Why it matters: The GTD/GoToDoc/Our People's Trust split is central to understanding who holds contracts, who holds CQC registration, and where governance is supposed to sit.

2022

City Health Centre was inspected by CQC in August 2022 and rated Good.
A July 2023 CQC review reportedly found no reason to reassess that rating at that stage.
Repo-local trend work suggests GTD's GP Patient Survey overall-experience line takes a real post-pandemic step down around 2022.
The working read is:
pre-break GTD mean sits roughly in the high 70s
there is a drop of around 15 percentage points
later recovery into 2024 is only partial, on the order of a couple of percentage points
the line appears to stabilise at roughly 12-13 points below a hypothetical no-shock counter-line
Working interpretation: this persistent gap is a useful high exclusion risk indicator, because it looks less like a bad year followed by recovery and more like a system settling at a worse level after a front-door / operating-model change.
Why it matters: City Health Centre is one of the cleaner GTD counterexamples in the otherwise weak GTD Manchester practice cluster.

2022 to 2025: survey disengagement / exclusion risk

Repo-local trend work suggests the response / completion side of the GP survey may also have sagged around the same period as the overall-good drop.
Working interpretation:
if satisfaction falls and survey response falls together, that is a bad sign
it does not prove exclusion by itself
but it is consistent with a story where some of the most worn-down or excluded patients stop engaging with the survey at all
in that reading, the visible dissatisfaction may understate the real deterioration because some of the lost patients disappear from the measurement frame
Why it matters: This is one of the cleaner routes from "bad experience" toward a stronger disengagement / exclusion claim, especially if it can be shown alongside Google decline and practice-level examples.

2023

January 2023

GTD commenced as Manchester SAS provider in January 2023, with roughly 100 SAS patients reportedly registered at City Health Centre.
Why it matters: This is one of the clearest public examples of GTD being used for difficult, security-sensitive, last-resort work rather than normal "nice to run" primary care.

February to June 2023

NHS GM / NECS reportedly began the later APMS procurement process with an RFI / market engagement phase in February 2023.
A public PIN/RFI then went out on 16 June 2023 under the same reference family later tied to the procurement.
Why it matters: The New Bank handover was in motion long before the public award notice. The process was deliberate and document-heavy.

September 2023

Stockport sought a one-year direct award to GTD for SAS while Greater Manchester explored whether a single SAS provider across GM was viable and whether the market could be tested.
Why it matters: This shows commissioner logic around GTD was already about continuity and provider-market thinness, not patient-review strength.

2024

March to July 2024: Manchester APMS procurement windows

Public inquiry synthesis gives this intended timetable for the 2024/25 procurement:
26 March 2024: tender publication
10 May 2024: bid deadline
23 May to 13 June 2024: evaluation
8 to 11 July 2024: due diligence
July/August 2024: recommended-bidder approvals
late 2024: standstill / award publication window
mid-October 2024 to March 2025: mobilisation
1 April 2025: go-live
Why it matters: There should be real dated records for each stage: evaluation packs, moderation notes, due-diligence outputs, approval papers and mobilisation plans.

17 July 2024

A Stockport Primary Care Commissioning Committee paper said:
GTD had held Stockport SAS since 2018
the locality had negotiated a reduced activity tariff
GTD had worked collaboratively with the primary care team
year-to-date activity suggested a 40% reduction versus the previous year's contract
Why it matters: This is one of the clearest public descriptions of why commissioners may retain GTD: tariff fit, continuity, and monitored delivery rather than patient satisfaction.

18 September 2024

Stockport public minutes reportedly said:
the reduced tariff had been agreed
the service was being monitored closely
the provider met quality requirements
there was no suitable in-borough accommodation with security
Why it matters: Estate/security constraints appear directly in public commissioner reasoning.

2024 quality-improvement / governance material

GTD's 2024 quality-improvement poster pack reportedly includes a Guide Bridge digital front door rollout.
The rollout playbook included:
communications planning
PPG involvement
website and phone-message updates
text templates
a detailed SOP
staffing models
clinical and access pathways
escalation routes
dashboards and auditable reporting
The same inquiry thread reports another GTD governance finding:
after reviewing 226 non-medical prescribers, 54% of those with prescribing access had incorrect prescribing rights
67% were fully compliant with GTD's prescribing-governance process
33% were outside the governance process
a wider system cleanse led to 1,456 colleagues being deactivated from clinical systems, with 354 more still needing deactivation but blocked by outstanding tasks
Why it matters: This is some of the strongest public-facing evidence that GTD already has internal operating playbooks and governance-cleanup work that map directly onto the access and safety concerns in this repo.

October to December 2024

The public award-stage trail says GM PCCC was asked in October 2024 to:
note the locality recommended-bidder reports
approve awards
approve award letters
approve publication after standstill
approve the next phase
A later December 2024 GM paper reportedly records:
the procurement challenge had delayed the process
locality teams were finalising signatures and handling transition
Manisha Kumar had a declared conflict regarding APMS procurement outcomes and the new provider for New Bank Health Centre
Why it matters: This is the clearest public trail so far for who sat in the formal decision chain and where the missing records are likely to sit.

2025

27 March 2025

Manchester Locality PCCC papers reportedly said all seven new Manchester APMS contracts were in final mobilisation for 1 April 2025.
The same paper reportedly said:
New Bank was moving from Better Health Manchester to GTD
New Bank would transfer from Better Health Manchester PCN to Ardwick & Longsight PCN
PCSE/ODS work, medicines-optimisation changes, ARRS resource re-estimation and locality support were part of transition planning
The same public paper also recorded the SAS risk:
the incumbent provider would not renew at current value
it wanted about a 23% increase in contract value
a STAR form had been submitted
only a short extension would be granted while alternatives were reviewed
Why it matters: March 2025 is the hinge point where the New Bank handover, GTD growth, and GTD's funding-pressure pushback are visible in the same public record.

1 April 2025

The new Manchester APMS contracts, including New Bank, were due to go live from 1 April 2025.
In the same procurement, GTD won:
New Bank
Charlestown
Simpson
City Health Centre
Public inquiry synthesis also says not all of these were equivalent "new wins":
Simpson and City Health Centre were incumbent retentions
the real fresh expansion in Manchester practice lots was mainly New Bank and Charlestown
Why it matters: This narrows the growth question. GTD was expanding, but not every listed win was a new takeover.

2 April 2025

GTD Healthcare Ltd has a Barclays fixed-and-floating charge dated 2 April 2025.
Why it matters: It is not proof of distress by itself, but it is a clear financing event immediately after the new contracts went live.

10 April to 6 May 2025

Manchester LMT reportedly agreed on 10 April 2025 to contract SAS for 2025/26 to Northern Health GPPO.
GTD was extended only briefly, first to 30 April 2025 and then effectively to 5 May 2025.
Northern Health GPPO reportedly commenced on 6 May 2025 from Victoria Mill Medical Centre.
Public reasons given for NHGPPO included:
prior SAS experience
no significant prior performance/quality issues
suitable estate ready to go
willingness to deliver within the existing budget
Why it matters: This is a real public case where GTD did not simply keep a difficult contract. The system moved elsewhere when another provider could carry the work at budget.

22 May 2025

Manchester PCCC papers reportedly confirmed:
GTD had been the previous SAS provider from Droylsden Road Family Practice
provider appetite for Manchester SAS had historically been weak
the service had moved to NHGPPO
Another key detail from this period: the locality had built SAS into the APMS service specification as a fallback option during the broader procurement in case nobody volunteered to run SAS.
Why it matters: This is one of the clearest public signs that commissioners were thinking in terms of provider resilience / willingness to absorb hard work, not just patient-facing quality.

8 July 2025

New Bank and Charlestown were reportedly registered by CQC to GoToDoc Limited on 8 July 2025.
Both reportedly state that CQC has not yet inspected the service under the new provider.
Why it matters: Public CQC status is stale for the exact sites people most want current answers about.

September 2025

Manchester contract reporting reportedly listed the new NHGPPO SAS contract at £100,833 for 2025/26.
Review cadence reportedly included quarterly contract reviews and monthly operational meetings.
Why it matters: This gives a public comparator for what ongoing contract-management visibility can look like, even though equivalent public APMS site dashboards for New Bank / Charlestown / Simpson / City are not visible.

November 2025

The inquiry thread reports one concrete Manchester paper issue at a GTD APMS site: Simpson Medical Practice had an estates risk around damp and waterproofing.
Why it matters: Publicly visible post-award issues do exist, but they appear patchy and site-specific rather than forming a clear public KPI trail.

December 2025

Inquiry synthesis of the 2025 filings says GTD group accounts to 31 March 2025 showed:
revenue around £49.3m
cost of sales around £37.4m
admin expenses around £11.6m
pre-tax profit around £203.6k
post-tax profit around £8.3k
average employees around 1,140
year-end cash around £2.35m
current liabilities around £10.6m
net assets around £2.04m
secured bank debt around £1.18m
Why it matters: This fits the "thin-margin, low-buffer operator" reading more than a cash-extraction story.

2025 to 2026 wider GTD activity

2025/26 contract activity outside New Bank

The inquiry thread reports additional public contract wins or service roles around this period, including:
Central Lancashire Integrated Urgent Care Service for 2025/26
Sefton Acute Home Visiting for 2025-2028
another Sefton urgent community response / acute home visiting service
care-home primary care services awarded under the Provider Selection Regime
Why it matters: GTD is not just a weak-surgery operator. It is being treated as wider urgent/community infrastructure.

Rapid-mobilisation / specialist work visible in public material

Inquiry synthesis says GTD public/internal material describes:
a Community Health Protection Response Service able to mobilise in 24-48 hours
migrant-health work for asylum seekers/refugees
vaccination and outbreak-response work
learning-disability/autism clinic work
Why it matters: Commissioners appear to use GTD where quick mobilisation and messy operational environments matter.

2026

21 January 2026

A later Stockport paper reportedly repeated continuity and close budget monitoring as the basis for retaining GTD in SAS-related work.
Why it matters: The commissioner logic did not materially change just because GTD had weak patient-facing reputation signals elsewhere.

Early 2026

Inquiry notes say Manchester public papers were also discussing:
wider primary-care funding instability for 2026/27
winter pressures
estates constraints
CQC's aged-rating / risk-based prioritisation problem
Why it matters: GTD's choices sit inside a stressed commissioning environment, not a neutral one.

10 March 2026

A local note captured in the inquiry thread summarised:
New Bank's 10-year APMS term with optional 5-year extension
PCN shift to Ardwick & Longsight
no new public CQC inspection for New Bank under the new provider
no obvious new distress signal beyond the already-known finance picture
Why it matters: By March 2026 the public oversight layer was still lagging behind the operational reality on the ground.

Undated structural items that matter throughout

Corporate / governance structure

Publicly visible group shape:
GTD Healthcare Ltd: contract-holding face in procurement records
GoToDoc Ltd: CQC-registered provider for relevant sites
Our People's Trust: single shareholder / employee-ownership vehicle
Missing from public view:
detailed board minutes
trust-board packs
growth-decision records
public annual explanations of 2024-25 expansion choices

Public operating stack

GTD publicly presents itself as having:
a 24/7 Clinical Hub in Denton
urgent-care and acute-visiting capability
referral-gateway clinical triage
formal patient-safety governance routes
a central complaints route
Working significance: some access failures that look local may actually be shaped by a central GTD operating layer.

Ecosystem / peer group

GTD's immediate world is not mainly made up of classic listed private chains.
The key recurring peer / competitor / collaborator set in the inquiry is:
Northern Health GPPO
Primary Care Manchester
South Manchester GP Federation
Manchester Primary Care Partnership
Mastercall
Bardoc
Salford Primary Care Together
Wigan GP Alliance
GMUPCA
Hope Citadel
Rochdale Health Alliance
Working significance: the same small set of provider bodies can be alliance partners in one setting and procurement rivals in another.

Public oversight limits

CQC is a weak near-real-time signal for several GTD practice sites because:
some ratings are inherited
some sites have not yet been inspected under the new provider
inspection frequency is risk-based and reduced compared with older inspection volume
Public APMS site dashboards for New Bank, Charlestown, Simpson and City Health Centre are still not obvious in the trail captured so far.

Missing records that would materially sharpen the picture

Procurement / award records

The three locality recommended bidder reports referenced in the December 2024 GM PCCC paper.
The full evaluation methodology, scoring matrix, weightings and pass/fail criteria for New Bank / Lot 3.
The moderation / consensus scoring notes for Lot 3.
The financial-standing and due-diligence assessments for GTD Healthcare Ltd and any delivery-entity checks tied to GoToDoc Ltd.
All conflict-of-interest declarations for evaluators, moderators and committee members linked to the procurement.
The contract award letter, the executed contract, and the KPI / access schedules for New Bank.
Any standstill challenge correspondence or decision records relating to New Bank / Lot 3.

Mobilisation / post-award records

The mobilisation / transition papers for the move from Better Health Manchester to GTD.
Any lot-specific APMS mobilisation packs for New Bank and Charlestown.
The site contract review / KPI dashboards for New Bank, Charlestown, Simpson and City Health Centre.
Any post-award remedial notices, contract-management letters, or escalation logs for those sites.

Operating-model / safety records

Any GTD board or trust-board records explaining 2024-25 growth decisions.
Any disclosable learning review / incident review behind the Leslie Swindells / Hattersley concerns.
Practice-by-practice GTD staffing and access metrics by quarter:

GP / nurse / ANP / receptionist WTE
vacancies
turnover
locum spend
call-answer data
request-closure reasons
callback failure rates
complaints
FFT
GP Patient Survey

Working synthesis as of 12 March 2026

GTD looks less like a simple "bad company buying practices" story and more like a thin-margin, regionally embedded risk absorber in a pressured Greater Manchester provider ecosystem.
Repo-local trend work currently points to two different failure layers: a slow-burn Google decline starting pre-pandemic, and a later post-pandemic GP-survey step-down that may reflect a broader access / exclusion break.
The strongest public explanation for why it keeps getting work is: continuity + mobilisation capacity + estate/security + willingness to hold difficult contracts + tariff/budget fit.
The strongest public explanation for why patients may still experience exclusion and poor access is: a triage-heavy, centralised, throughput-protective operating model under workforce and funding pressure.
The biggest current gaps are no longer vague: they are specific missing procurement, mobilisation, contract-management and site-performance records.